144 related articles for article (PubMed ID: 37271980)
1. Psychometric Validation and Meaningful Change Thresholds of the New Nasal Polyposis Symptom Diary.
Shih VH; Slagle AF; Ivanescu C; Flore G; Meyers O; Kreindler J; Martin UJ; Werkström V
Ann Otol Rhinol Laryngol; 2023 Dec; 132(12):1638-1648. PubMed ID: 37271980
[TBL] [Abstract][Full Text] [Related]
2. Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study.
Fokkens W; Trigg A; Lee SE; Chan RH; Diamant Z; Hopkins C; Howarth P; Lund V; Mayer B; Sousa AR; Yancey S; Tabberer M;
J Patient Rep Outcomes; 2023 Jan; 7(1):4. PubMed ID: 36662344
[TBL] [Abstract][Full Text] [Related]
3. Estimating Clinically Meaningful Change of Efficacy Outcomes in Inadequately Controlled Chronic Rhinosinusitis with Nasal Polyposis.
Han JK; Bachert C; Lee SE; Hopkins C; Heffler E; Hellings PW; Peters AT; Kamat S; Whalley D; Qin S; Nelson L; Siddiqui S; Khan AH; Li Y; Mannent LP; Guillemin I; Chuang CC
Laryngoscope; 2022 Feb; 132(2):265-271. PubMed ID: 34850966
[TBL] [Abstract][Full Text] [Related]
4. Validation of the PRUCISION Instruments in Pediatric Patients with Progressive Familial Intrahepatic Cholestasis.
Gwaltney C; Ivanescu C; Karlsson L; Warholic N; Kjems L; Horn P
Adv Ther; 2022 Nov; 39(11):5105-5125. PubMed ID: 36066745
[TBL] [Abstract][Full Text] [Related]
5. Psychometric Evaluation of a New Patient-Reported Outcome (PRO) Symptom Diary for Varicose Veins: VVSymQ(®) Instrument.
Wright DD; Paty J; Turner-Bowker DM; Bradbury A
Patient; 2016 Aug; 9(4):335-48. PubMed ID: 27016239
[TBL] [Abstract][Full Text] [Related]
6. Measuring the patient experience of chronic rhinosinusitis with nasal polyposis: qualitative development of a novel symptom diary.
O'Quinn S; Shih VH; Martin UJ; Meyers O; Crooks P; Bailey J; Slagle AF
Int Forum Allergy Rhinol; 2022 Aug; 12(8):996-1005. PubMed ID: 34921526
[TBL] [Abstract][Full Text] [Related]
7. Psychometric validation and meaningful within-patient change of the Migraine-Specific Quality of Life questionnaire version 2.1 electronic patient-reported outcome in patients with episodic and chronic migraine.
Speck RM; Yu R; Ford JH; Ayer DW; Bhandari R; Wyrwich KW
Headache; 2021 Mar; 61(3):511-526. PubMed ID: 33481276
[TBL] [Abstract][Full Text] [Related]
8. Development and Psychometric Validation of a Patient-Reported Outcome Measure to Assess the Signs and Symptoms of Chronic Hand Eczema: The Hand Eczema Symptom Diary (HESD).
Molin S; Larsen LS; Joensson P; Oesterdal ML; Arbuckle R; Grant L; Skingley G; Schuttelaar MLA
Dermatol Ther (Heidelb); 2024 Mar; 14(3):643-669. PubMed ID: 38485862
[TBL] [Abstract][Full Text] [Related]
9. Meaningful changes for efficacy outcomes in patients with chronic rhinosinusitis with nasal polyps.
Braid J; Islam L; Gugiu C; Omachi TA; Doll H
World Allergy Organ J; 2023 May; 16(5):100776. PubMed ID: 37214171
[TBL] [Abstract][Full Text] [Related]
10. Evaluation and performance of a newly developed patient-reported outcome instrument for diarrhea-predominant irritable bowel syndrome in a clinical study population.
Delgado-Herrera L; Lasch K; Zeiher B; Lembo AJ; Drossman DA; Banderas B; Rosa K; Lademacher C; Arbuckle R
Therap Adv Gastroenterol; 2017 Sep; 10(9):673-687. PubMed ID: 28932269
[TBL] [Abstract][Full Text] [Related]
11. Development of Sinonasal Outcome Test (SNOT-22) Domains in Chronic Rhinosinusitis With Nasal Polyps.
Khan AH; Reaney M; Guillemin I; Nelson L; Qin S; Kamat S; Mannent L; Amin N; Whalley D; Hopkins C
Laryngoscope; 2022 May; 132(5):933-941. PubMed ID: 34437720
[TBL] [Abstract][Full Text] [Related]
12. Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM), a Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Data from the BE VIVID and BE READY Phase 3 Trials.
Warren RB; Gottlieb AB; Merola JF; Garcia L; Cioffi C; Peterson L; Pelligra C; Ciaravino V
Dermatol Ther (Heidelb); 2021 Oct; 11(5):1551-1569. PubMed ID: 34260044
[TBL] [Abstract][Full Text] [Related]
13. Psychometric validation and testing of the 10-item pediatric daily chest-related electronic patient reported outcome (ePRO) diary.
Arbuckle R; Shea T; Burrows K; Marshall C; Trigg A; Stein J; Albrecht HH
J Patient Rep Outcomes; 2023 Jan; 7(1):6. PubMed ID: 36695911
[TBL] [Abstract][Full Text] [Related]
14. Assessment of health-related quality-of-life in patients with chronic Rhinosinusitis - Validation of the German Sino-Nasal Outcome Test-22 (German-SNOT-22).
Riedl D; Dejaco D; Steinbichler TB; Innerhofer V; Gottfried T; Bektic-Tadic L; Giotakis AI; Rumpold G; Riechelmann H
J Psychosom Res; 2021 Jan; 140():110316. PubMed ID: 33271403
[TBL] [Abstract][Full Text] [Related]
15. Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM): A Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Reported Data from the BE RADIANT Phase 3b Trial.
Gottlieb AB; Warren RB; Augustin M; Garcia L; Cioffi C; Peterson L; Pelligra C; Ciaravino V
Adv Ther; 2021 Oct; 38(10):5253-5269. PubMed ID: 34471992
[TBL] [Abstract][Full Text] [Related]
16. Fabry Disease Patient-Reported Outcome (FD-PRO) demonstrates robust measurement properties for assessing symptom severity in Fabry disease.
Hamed A; DasMahapatra P; Lyn N; Gwaltney C; Iaconangelo C; Serrano D; Modur V; Politei J
Mol Genet Metab Rep; 2021 Dec; 29():100824. PubMed ID: 34900595
[TBL] [Abstract][Full Text] [Related]
17. Item-level psychometric properties for a new patient-reported psoriasis symptom diary.
Strober BE; Nyirady J; Mallya UG; Guettner A; Papavassilis C; Gottlieb AB; Elewski BE; Turner-Bowker DM; Shields AL; Gwaltney CJ; Lebwohl M
Value Health; 2013; 16(6):1014-22. PubMed ID: 24041351
[TBL] [Abstract][Full Text] [Related]
18. Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis.
Gossec L; Orbai AM; Coates LC; Gladman DD; Ogdie A; Pelligra CG; Ciaravino V; Ink B; Taieb V; Lambert J; de Wit M
RMD Open; 2024 Jan; 10(1):. PubMed ID: 38296802
[TBL] [Abstract][Full Text] [Related]
19. Psychometric evaluation of the Symptoms of Infection with Coronavirus-19 (SIC): results from a cross-sectional study and a phase 3 clinical trial.
Chan EKH; Williams V; Romano C; Fehnel S; Slagle AF; Stoddard J; Sadoff J; Mayorga M; Lewis S; Yarr S; Ma J; Liu Y; Katz EG; McNulty P; van Dromme I; McQuarrie K
J Patient Rep Outcomes; 2023 May; 7(1):45. PubMed ID: 37195456
[TBL] [Abstract][Full Text] [Related]
20. Psychometric validity of the 22-item Sinonasal Outcome Test.
Hopkins C; Gillett S; Slack R; Lund VJ; Browne JP
Clin Otolaryngol; 2009 Oct; 34(5):447-54. PubMed ID: 19793277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]